Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05069038
Title Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.